In contrast to CD8+ T cells, which play an immune-supportive role in the TME, adenosine-producing CD39+ and CD73+ Treg are important factors in the inhibition of anti-tumor immunity and associated with poor outcome [8,9]. Here, ENTPD1 is linked to neoplasm.